CMMB Earnings Chemomab Therapeutics Ltd.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–8 of 8
| Q1 2023 | 2023-03-31 | 0.04 | 2023-05-11 | 10-Q |
| FY 2022 | 2022-12-31 | 0.12 | 2023-03-20 | 10-K |
| Q3 2022 | 2022-09-30 | 0.09 | 2022-11-10 | 10-Q |
| Q2 2022 | 2022-06-30 | 0.05 | 2022-08-12 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.02 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | 0.06 | 2023-03-20 | 10-K |
| Q3 2022 | 2021-09-30 | 0.04 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.02 | 2022-08-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.